143 related articles for article (PubMed ID: 12427424)
1. Influence of propranolol, enalaprilat, verapamil, and caffeine on adenosine A(2A)-receptor-mediated coronary vasodilation.
Riou LM; Ruiz M; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA; Glover DK
J Am Coll Cardiol; 2002 Nov; 40(9):1687-94. PubMed ID: 12427424
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological stress myocardial perfusion imaging with the potent and selective A(2A) adenosine receptor agonists ATL193 and ATL146e administered by either intravenous infusion or bolus injection.
Glover DK; Ruiz M; Takehana K; Petruzella FD; Riou LM; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
Circulation; 2001 Sep; 104(10):1181-7. PubMed ID: 11535577
[TBL] [Abstract][Full Text] [Related]
3. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies.
Sudhir K; MacGregor JS; Gupta M; Barbant SD; Redberg R; Yock PG; Chatterjee K
Circulation; 1993 Mar; 87(3):931-8. PubMed ID: 8383016
[TBL] [Abstract][Full Text] [Related]
4. Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
Glover DK; Riou LM; Ruiz M; Sullivan GW; Linden J; Rieger JM; Macdonald TL; Watson DD; Beller GA
Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1851-8. PubMed ID: 15591104
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin mediates coronary vasodilation through adenosine receptors and KATP channels.
Sabates BL; Pigott JD; Choe EU; Cruz MP; Lippton HL; Hyman AL; Flint LM; Ferrara JJ
J Surg Res; 1997 Feb; 67(2):163-8. PubMed ID: 9073563
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotection by adenosine A2A agonists in a canine model of myocardial stunning produced by multiple episodes of transient ischemia.
Glover DK; Ruiz M; Takehana K; Petruzella FD; Rieger JM; Macdonald TL; Watson DD; Linden J; Beller GA
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3164-71. PubMed ID: 17308004
[TBL] [Abstract][Full Text] [Related]
8. Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels.
Berwick ZC; Payne GA; Lynch B; Dick GM; Sturek M; Tune JD
Microcirculation; 2010 Nov; 17(8):600-7. PubMed ID: 21044214
[TBL] [Abstract][Full Text] [Related]
9. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
[TBL] [Abstract][Full Text] [Related]
10. Selective A2A adenosine receptor agonist as a coronary vasodilator in conscious dogs: potential for use in myocardial perfusion imaging.
Trochu JN; Zhao G; Post H; Xu X; Belardinelli L; Belloni FL; Hintze TH
J Cardiovasc Pharmacol; 2003 Jan; 41(1):132-9. PubMed ID: 12500031
[TBL] [Abstract][Full Text] [Related]
11. Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonist.
Patel RA; Glover DK; Broisat A; Kabul HK; Ruiz M; Goodman NC; Kramer CM; Meerdink DJ; Linden J; Beller GA
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H637-42. PubMed ID: 19502555
[TBL] [Abstract][Full Text] [Related]
12. Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.
Sanjani MS; Teng B; Krahn T; Tilley S; Ledent C; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2322-33. PubMed ID: 21949117
[TBL] [Abstract][Full Text] [Related]
13. Comparative profile of vasodilation by CVT-3146, a novel A2A receptor agonist, and adenosine in conscious dogs.
Zhao G; Linke A; Xu X; Ochoa M; Belloni F; Belardinelli L; Hintze TH
J Pharmacol Exp Ther; 2003 Oct; 307(1):182-9. PubMed ID: 12954805
[TBL] [Abstract][Full Text] [Related]
14. Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery.
Prior HM; Yates MS; Beech DJ
Br J Pharmacol; 1999 Jan; 126(2):494-500. PubMed ID: 10077243
[TBL] [Abstract][Full Text] [Related]
15. Caffeine attenuates the duration of coronary vasodilation and changes in hemodynamics induced by regadenoson (CVT-3146), a novel adenosine A2A receptor agonist.
Zhao G; Messina E; Xu X; Ochoa M; Sun HL; Leung K; Shryock J; Belardinelli L; Hintze TH
J Cardiovasc Pharmacol; 2007 Jun; 49(6):369-75. PubMed ID: 17577101
[TBL] [Abstract][Full Text] [Related]
16. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
Mekkaoui C; Jadbabaie F; Dione DP; Meoli DF; Purushothaman K; Belardinelli L; Sinusas AJ
JACC Cardiovasc Imaging; 2009 Oct; 2(10):1198-208. PubMed ID: 19833310
[TBL] [Abstract][Full Text] [Related]
17. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy.
Wittstein IS; Kass DA; Pak PH; Maughan WL; Fetics B; Hare JM
J Am Coll Cardiol; 2001 Aug; 38(2):429-35. PubMed ID: 11499734
[TBL] [Abstract][Full Text] [Related]
18. Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism.
Reece TB; Kron IL; Okonkwo DO; Laurent JJ; Tache-Leon C; Maxey TS; Ellman PI; Linden J; Tribble CG; Kern JA
J Vasc Surg; 2006 Aug; 44(2):392-7. PubMed ID: 16890874
[TBL] [Abstract][Full Text] [Related]
19. Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation.
Peirce SM; Skalak TC; Rieger JM; Macdonald TL; Linden J
Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H67-74. PubMed ID: 11406470
[TBL] [Abstract][Full Text] [Related]
20. NTS A(2a) purinoceptor activation elicits hindlimb vasodilation primarily via a beta-adrenergic mechanism.
Kitchen AM; Scislo TJ; O'Leary DS
Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H1775-82. PubMed ID: 10843872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
